CTC
TRIB

Central Trust Company’s Trinity Biotech TRIB Stock Holding History

Central Trust Company’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-67
Closed -$6K – 1226
2014
Q3 		$6K Hold
67
– – ﹤0.01% 1061
2014
Q2 		$8K Hold
67
– – ﹤0.01% 1005
2014
Q1 		$8K Buy
+67
New +$8.78K ﹤0.01% 994

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Central Trust Company's TRIB Position: Q4 2014 in Review

Central Trust Company sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 67 shares — an estimated $6K sold.

Central Trust Company first reported a position in TRIB in Q1 2014 and held it in 3 quarters. The position peaked at $8K in Q2 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Central Trust Company reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Central Trust Company sold 67 Trinity Biotech shares in Q4 2014, an estimated $6K.
  • Central Trust Company first reported a position in Trinity Biotech in Q1 2014 and held it in 3 quarters.
  • Central Trust Company's Trinity Biotech position peaked at $8K in Q2 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Central Trust Company's 13F filing for Q4 2014, filed 16 Jan 2015.